AeroVironment Inc. (AVAV) secured a $75 million task order from the U.S. Air Force to develop next‑generation biotechnology and smart materials under the Functional Responsive Experimentation for Systems and Humans (FRESH) program at Wright Patterson Air Force Base. The order is being executed by the company’s UES division, which specializes in advanced materials and autonomous systems.
The award adds a new, funded revenue stream that is expected to contribute to the company’s FY26 guidance of $1.9 billion to $2.0 billion. It also expands AeroVironment’s autonomous systems portfolio, positioning the firm to capture a share of the growing market for high‑performance smart materials. The contract follows the company’s May 2025 acquisition of BlueHalo, which broadened its capabilities in drone swarms, counter‑drone technology, and directed energy, and signals a continued focus on integrating biology and materials science into defense solutions.
AeroVironment’s FY25 revenue reached $821 million, up 14% year‑over‑year, while Q4 FY25 revenue was $275 million, a 40% increase. Q1 FY26 revenue rose to $454.7 million, a 140% jump, and the company’s funded backlog stood at $726 million as of FY25. The $75 million task order represents a meaningful addition to this backlog and provides a near‑term, fully funded project that will help the company meet its revenue targets for the year.
Dr. John Hogan, Vice President of Defense and Interagency Services, said, “We’re entering an era where biology and materials science are converging.” The quote underscores the strategic intent behind the contract and the company’s broader push to leverage advanced materials for defense applications.
Investors have remained cautious, citing valuation concerns and a recent setback involving a U.S. Space Force contract suspension. Despite these headwinds, the new Air Force order adds confidence that AeroVironment can secure high‑value, funded work in a critical growth area.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.